Company name |
Beschreibung |
|---|---|
| Alere |
Healthcare Management |
| AIS LIMS |
LIMS Software |
| AGY Therapeutics Inc. |
Discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system |
| Agilent Technologies GmbH |
Provider of instrumentation, supplies, software and services to the life science and chemical analysis markets |
| AgileBio |
AgileBio is a team solution provider: Collaborative and Intranet software creator for biotech players. |
| Affymetrix |
Microarray technology and genomics analysis |
| Affymax |
Discover, develop and deliver therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses. |
| Affitech |
Construction of human antibodies, using in vitro display and screening technology. |
| Affinium Pharmaceuticals |
Germinated from assets acquired in 2003 from GSK, Affinium's antibacterial programs now include a broad base of intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors, genes, proteins, assays, crystal structures and combin |
| Affibody |
Biopharmaceuticals based on proprietary technology platforms: Affibody® molecules and Albumod™. |
| Advion BioSciences |
Bioanalytical contract services to the pharmaceutical industry |
| Advanced ChemTech |
Peptide-based pharmaceutical research and manufacturing, and innovative medical device design and development |
| ActivX Biosciences, Inc. |
Discovers and develops small molecule drugs for major unmet medical needs. Identifies target and off-target activities of drug candidates in the protein kinase and protease families with an initial focus on the areas of hematology, oncology, metabolic and inflammatory diseases. |
| ACE BioSciences A/S |
Discovers and develops novel products to fight serious life threatening diseases |
| Accelrys |
Based on its analysis of the integrated insilico drug discovery solutions market, Frost & Sullivan recognized Accelrys, Inc., with the 2010 North America Frost & Sullivan Award for New Product Innovation of the Year. |
| ACADIA |
Biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders |
| AbSorber |
AbSorber AB is a biotech company focused on developing products that increase the probability of transplantation success. XM-ONE®, the first AbSorber product on the market, is a CE-marked and FDA registered transplantation crossmatch test kit. |
| Able Software |
Able Software 3D DOCTOR R2V |
| Abgent Antibodies and Peptides |
Genome wide antibody coverage with an emphasis on autophagy, stem cells, and neurodegenerative diseases |
| Abcam plc. |
Antibodies & Reagents, find any antibody. |